Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enwei Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and chemical drugs. The company is best known for its flagship brand, Jieeryin, which includes a range of gynecological and dermatological treatments that have achieved significant market share in China. Beyond its core focus on women's health, Enwei Pharmaceutical produces a diverse portfolio of products covering pediatric care, respiratory health, and chronic disease management. The company operates integrated manufacturing facilities and maintains a robust distribution network across mainland China, leveraging both modern pharmacological research and traditional herbal formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Enwei Chinese Medicine Research and Development.